#ESMO21 Highlights on nivolumab in pretreated thymoma & thymic carcinoma: EORTC-ETOP NIVOTHYM st

1 Views
administrator
administrator
07/18/23

Nicolas Girard reports on key results from ESMO Congress 2021 on LBA66 - Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial

Produced by the European Society for Medical Oncology
http://oncologypro.esmo.org

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next